For Generic Vancocin, An Advisory Committee Role Reversal
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA will essentially play the part of a sponsor during the Aug. 4 pharmaceutical science panel meeting, arguing for favorable approval standards, while the brand sponsor, ViroPharma, will play the role of skeptic.